BioXcel Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
BioXcel Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q3 2018 to Q2 2024.
  • BioXcel Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $87K, unchanged year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $87K $0 0% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $87K -$838K -90.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $87K -$838K -90.6% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $87K -$838K -90.6% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $87K -$838K -90.6% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $925K -$40K -4.15% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $925K +$839K +976% Dec 31, 2022 10-K 2024-03-22
Q3 2022 $925K -$830K -47.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $925K -$705K -43.3% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $965K +$332K +52.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $86K -$1K -1.15% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $1.76M +$1.67M +1941% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $1.63M +$1.58M +3096% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $633K +$582K +1141% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $87K +$36K +70.6% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $86K +$35K +68.6% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $51K $0 0% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $51K $0 0% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $51K $0 0% Dec 31, 2019 10-K 2021-03-12
Q3 2019 $51K $0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $51K Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $51K Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $51K Dec 31, 2018 10-K 2020-03-09
Q3 2018 $51K Sep 30, 2018 10-Q 2018-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.